Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of Inovio Pharmaceuticals Inc. (NYSE: INO) – a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Inovio’s shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. Inovio shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Featured Story

    How to Profit if the Nigeria Elections Drive Up Oil Prices

    Oil prices are on the rise for a bevy of reasons - soaring demand in emerging markets, the weak dollar, and a strengthening U.S. recovery, to name a few.

    However, supply disruptions and civil unrest in the Middle East-North Africa (MENA) region in recent months have had the biggest impact on oil prices. Egypt, Libya and Yemen have all played a part in driving up oil prices, and now they're about to be joined by another volatile oil producer.

    I'm talking about Nigeria.


    Read More...
  • rising oil prices